Richter Gedeon Nyrt (RICHTER):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Richter Gedeon Nyrt (RICHTER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9892
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ハンガリー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological diseases, cardiovascular diseases, gastrointestinal diseases and central nervous system disorders. Richter’s research activities focus exclusively on the development of original small molecules, recombinant biotechnology and generic product development. It operates sales network in Hungary, Central Eastern Europe and the Commonwealth of Independent States (CIS) countries. The company has a research and development unit in Central Eastern Europe. Richter is headquartered in Budapest, Hungary.

Richter Gedeon Nyrt (RICHTER) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Richter Gedeon Nyrt, Medical Devices Deals, 2012 to YTD 2018 11
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Gedeon Richter Acquires Bemfola US Rights from Fertility Biotech 14
Gedeon Richter Acquires Esmya from Laboratoire HRA Pharma 15
Venture Financing 16
Finox Biotech Raises US$24.4 Million In Venture Financing 16
Partnerships 17
Evestra Enters into Agreement with Gedeon Richter 17
Gedeon Richter Enters into Distribution Agreement with Allergan 18
BMV Medica Enters into Marketing Agreement with Gedeon Richter Mexico 19
Evestra Enters Into R&D Agreement With Gedeon Richter For Contraceptive Products 20
Orion Enters Into R&D Agreement With Gedeon Richter For Cognitive Disorders 21
Gedeon Richter Forms Joint Venture With Rxmidas Pharma 22
Licensing Agreements 23
Gedeon Richter Enters into Licensing Agreement with Collins 23
Richter Gedeon Enters into Licensing Agreement with Mithra Pharma 24
Richter Gedeon Enters into Licensing Agreement with Pharmanest 25
Richter Gedeon Enters into Licensing Agreement with DM Bio 26
Recordati Enters into Licensing Agreement with Gedeon Richter for Cariprazine 27
Mithra Pharmaceuticals Enters into Licensing Agreement with Gedeon Richter 28
Gedeon Richter Enters into Licensing Agreement with Bayer HealthCare 29
Gedeon Richter Enters Into Licensing Agreement With Acrux For Estradiol Skin Spray 30
STADA Arzneimittel Enters into Licensing Agreement with Gedeon Richter 31
Gedeon Richter Expands Licensing Agreement With HRA Pharma For Esmya 32
Equity Offering 33
Gedeon Richter Romania Plans to Raise USD2.5 Million in Private Placement of Shares 33
Finox Biotech Raises USD21.4 Million in Private Placement of Shares 34
Acquisition 35
Gedeon Richter Acquires Finox for USD193.8 Million 35
Gedeon Richter Acquires Remaining 50% Joint Venture Stake in Gedeon Richter Rxmidas from Rxmidas Pharma 36
Gedeon Richter Acquires Majority Stake in Mediplus 37
Richter Gedeon Acquires 70% Stake In DNA Pharma 38
Richter Acquires 51% Stake In Next Pharma 39
Richter Gedeon Nyrt – Key Competitors 40
Richter Gedeon Nyrt – Key Employees 41
Richter Gedeon Nyrt – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Joint Venture 44
Recent Developments 45
Product News 45
05/18/2017: Gedeon Richter Receives CHMP Positive Opinion for Reagila (cariprazine) 45
Product Approvals 46
Mar 08, 2017: FDA Accepts Supplemental New Drug Application For VRAYLAR (cariprazine) 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Richter Gedeon Nyrt, Deals By Therapy Area, 2012 to YTD 2018 9
Richter Gedeon Nyrt, Medical Devices Deals, 2012 to YTD 2018 11
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Gedeon Richter Acquires Bemfola US Rights from Fertility Biotech 14
Gedeon Richter Acquires Esmya from Laboratoire HRA Pharma 15
Finox Biotech Raises US$24.4 Million In Venture Financing 16
Evestra Enters into Agreement with Gedeon Richter 17
Gedeon Richter Enters into Distribution Agreement with Allergan 18
BMV Medica Enters into Marketing Agreement with Gedeon Richter Mexico 19
Evestra Enters Into R&D Agreement With Gedeon Richter For Contraceptive Products 20
Orion Enters Into R&D Agreement With Gedeon Richter For Cognitive Disorders 21
Gedeon Richter Forms Joint Venture With Rxmidas Pharma 22
Gedeon Richter Enters into Licensing Agreement with Collins 23
Richter Gedeon Enters into Licensing Agreement with Mithra Pharma 24
Richter Gedeon Enters into Licensing Agreement with Pharmanest 25
Richter Gedeon Enters into Licensing Agreement with DM Bio 26
Recordati Enters into Licensing Agreement with Gedeon Richter for Cariprazine 27
Mithra Pharmaceuticals Enters into Licensing Agreement with Gedeon Richter 28
Gedeon Richter Enters into Licensing Agreement with Bayer HealthCare 29
Gedeon Richter Enters Into Licensing Agreement With Acrux For Estradiol Skin Spray 30
STADA Arzneimittel Enters into Licensing Agreement with Gedeon Richter 31
Gedeon Richter Expands Licensing Agreement With HRA Pharma For Esmya 32
Gedeon Richter Romania Plans to Raise USD2.5 Million in Private Placement of Shares 33
Finox Biotech Raises USD21.4 Million in Private Placement of Shares 34
Gedeon Richter Acquires Finox for USD193.8 Million 35
Gedeon Richter Acquires Remaining 50% Joint Venture Stake in Gedeon Richter Rxmidas from Rxmidas Pharma 36
Gedeon Richter Acquires Majority Stake in Mediplus 37
Richter Gedeon Acquires 70% Stake In DNA Pharma 38
Richter Acquires 51% Stake In Next Pharma 39
Richter Gedeon Nyrt, Key Competitors 40
Richter Gedeon Nyrt, Key Employees 41
Richter Gedeon Nyrt, Other Locations 42
Richter Gedeon Nyrt, Subsidiaries 42
Richter Gedeon Nyrt, Joint Venture 44

List of Figures
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Richter Gedeon Nyrt, Medical Devices Deals, 2012 to YTD 2018 11

★海外企業調査レポート[Richter Gedeon Nyrt (RICHTER):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Duke University Health System Inc:企業の戦略的SWOT分析
    Duke University Health System Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • KINeSYS Inc.:企業の戦略・SWOT・財務情報
    KINeSYS Inc. - Strategy, SWOT and Corporate Finance Report Summary KINeSYS Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ansaldo Energia SpA:企業の戦略的SWOT分析
    Ansaldo Energia SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Snowy Hydro Ltd:電力:M&Aディール及び事業提携情報
    Summary Snowy Hydro Ltd (Snowy Hydro) is an integrated energy utility. It has presence in the energy vertical, from generating energy, providing price risk management products for wholesale customers, and delivering energy to homes and businesses. The company produces electricity from gas, hydro, an …
  • PLC SPA (IIN):電力:M&Aディール及び事業提携情報
    Summary PLC SPA (PLC Group) formerly Industria e Innovazione S.p.A, is a provider of design, installation, and maintenance services for electrical infrastructures and renewable energy plants. The company’s service offerings include engineering, procurement, and construction (EPC); manufacturing and …
  • International Data Group:戦略・SWOT・企業財務分析
    International Data Group - Strategy, SWOT and Corporate Finance Report Summary International Data Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Calixar SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Calixar SAS (Calixar) is a provider of solutions to develop conformational antibodies. The company offers production, Solubilization, extraction, purification, stabilization and crystallization of functional membrane proteins and antigens. It offers technology to discover and validate the po …
  • Chesswood Group Ltd (CHW):企業の財務・戦略的SWOT分析
    Chesswood Group Ltd (CHW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Soleno Therapeutics Inc (SLNO):医療機器:M&Aディール及び事業提携情報
    Summary Soleno Therapeutics Inc (Soleno), formerly Capnia Inc is a medical equipment company that designs, develops and commercializes novel therapeutic and diagnostic products. The company provides products such as serenz, cosense, and others. It offers serenz which is a hand-held device, which is …
  • InterOil Exploration & Production ASA Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    InterOil Exploration & Production ASA Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary InterOil Exploration & Production ASA (InterOil Exploration & Production) is an oil and gas company that provides petroleum exploration services. The company acquires, explores, …
  • Bright Horizons Family Solutions LLC (BFAM):企業の財務・戦略的SWOT分析
    Summary Bright Horizons Family Solutions LLC (Bright Horizons) is a provider of educational advisory services and child care services. The company offers curriculum and programs including early education and preschool, back-up child and adult care programs, infant care, toddler care, college coach, …
  • Agilysys Inc (AGYS):企業の財務・戦略的SWOT分析
    Agilysys Inc (AGYS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Intrexon Corp (XON)-医療機器分野:企業M&A・提携分析
    Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a provider of therapeutic solutions. The company operates through its divisions such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therap …
  • X4 Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary X4 Pharmaceuticals Inc (X4 Pharma) is a pharmaceutical company that develops novel therapeutics to treat cancer and rare diseases. The company’s lead drug candidate, X4P-001-LD, is in Phase 2/3 trial used for the treatment for patients with WHIM and other immunodeficiency disease. It also de …
  • Vericel Corp (VCEL):医療機器:M&Aディール及び事業提携情報
    Summary Vericel Corp (Vericel) develops and markets advanced cell therapies for sports medicine and severe burn domains. Its major products include MACI (autologous cultured chondrocytes on porcine collagen membrane) for the treatment of cartilage defects; and Epicel cultured epidermal autografts fo …
  • UnitedHealth Group Incorporated:企業の戦略・SWOT・財務分析
    UnitedHealth Group Incorporated - Strategy, SWOT and Corporate Finance Report Summary UnitedHealth Group Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Inretail Peru Corp. (INRETC1):企業の財務・戦略的SWOT分析
    Inretail Peru Corp. (INRETC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Citius Pharmaceuticals Inc (CTXR):企業の財務・戦略的SWOT分析
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • Berkshire Hathaway Energy:企業の戦略・SWOT・財務分析
    Berkshire Hathaway Energy - Strategy, SWOT and Corporate Finance Report Summary Berkshire Hathaway Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • HomeWorks Tri-County Electric Cooperative Inc:発電所・企業SWOT分析
    HomeWorks Tri-County Electric Cooperative Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆